Home
OCX
OCX News

Latest Oncocyte Corporation (OCX) News on June 4, 2025

Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology

GlobeNewswire

16 days ago

Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology

OncoCyte Corp (OCX) Q1 2025 Earnings Call Highlights: Strategic Advances in Transplant Testing ...

GuruFocus.com

22 days ago

OncoCyte Corp (OCX) Q1 2025 Earnings Call Highlights: Strategic Advances in Transplant Testing ...

Oncocyte Reports Q1 2025 Results and Business Progress

GlobeNewswire

23 days ago

Oncocyte Reports Q1 2025 Results and Business Progress

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

GlobeNewswire

a month ago

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte Provides Positive Update on Clinical Trial Progress

GlobeNewswire

a month ago

Oncocyte Provides Positive Update on Clinical Trial Progress

Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity

GlobeNewswire

a month ago

Oncocyte’s Proprietary Assay Demonstrates Long-Term Clinical Validity

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

2 months ago

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

GlobeNewswire

2 months ago

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025

GlobeNewswire

3 months ago

Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025

OncoCyte Corporation (OCX): Among Cheapest Stocks Insiders Are Buying Recently

Insider Monkey

3 months ago

OncoCyte Corporation (OCX): Among Cheapest Stocks Insiders Are Buying Recently

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 02/13/2025

OncoCyte prices $29.1M equity offering

TipRanks

4 months ago

OncoCyte prices $29.1M equity offering

Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire

4 months ago

Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Oncocyte Prices $29.1 Million Equity Offering

GlobeNewswire

4 months ago

Oncocyte Prices $29.1 Million Equity Offering

Insider Stock Buying Reaches US$508.4k On OncoCyte

Simply Wall St.

4 months ago

Insider Stock Buying Reaches US$508.4k On OncoCyte

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

GlobeNewswire

5 months ago

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

GlobeNewswire

5 months ago

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

GlobeNewswire

6 months ago

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

GlobeNewswire

6 months ago

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms

GlobeNewswire

6 months ago

Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms

OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress in Transplant Testing and ...

GuruFocus.com

7 months ago

OncoCyte Corp (OCX) Q3 2024 Earnings Call Highlights: Progress in Transplant Testing and ...

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

GlobeNewswire

7 months ago

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12

GlobeNewswire

7 months ago

Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12

Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles

GlobeNewswire

8 months ago

Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

GlobeNewswire

8 months ago

Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 10/07/2024

OncoCyte Secures Funding Through Private Share Sale

TipRanks

8 months ago

OncoCyte Secures Funding Through Private Share Sale

Oncocyte Signs Leading Transplant Centers in US and Germany

GlobeNewswire

8 months ago

Oncocyte Signs Leading Transplant Centers in US and Germany

Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

8 months ago

Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology

GlobeNewswire

9 months ago

PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

GlobeNewswire

10 months ago

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results

GlobeNewswire

10 months ago

Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

GlobeNewswire

10 months ago

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode

GlobeNewswire

a year ago

MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode

Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move

GlobeNewswire

a year ago

Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move

Oncocyte Appoints Andrea James as Chief Financial Officer

GlobeNewswire

a year ago

Oncocyte Appoints Andrea James as Chief Financial Officer

OncoCyte's Innovative Approach: Potential in Precision Diagnostics

ACCESSWIRE

a year ago

OncoCyte's Innovative Approach: Potential in Precision Diagnostics

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study

GlobeNewswire

a year ago

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study

Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine

GlobeNewswire

a year ago

Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine

Oncocyte Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Oncocyte Reports First Quarter 2024 Financial Results

Oncocyte to Announce First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Oncocyte to Announce First Quarter 2024 Financial Results

PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace

GlobeNewswire

a year ago

PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics Marketplace

Oncocyte Reports Full Year 2023 Financial Results

GlobeNewswire

a year ago

Oncocyte Reports Full Year 2023 Financial Results

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

GlobeNewswire

a year ago

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

GlobeNewswire

a year ago

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

a year ago

Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results

PodcastOne (Nasdaq: PODC) to Announce Third Quarter Fiscal 2024 Financial Results and Host Investor Webcast on February 8, 2024

GlobeNewswire

a year ago

PodcastOne (Nasdaq: PODC) to Announce Third Quarter Fiscal 2024 Financial Results and Host Investor Webcast on February 8, 2024

NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces Distributions

PR Newswire

a year ago

NXG Cushing® Midstream Energy Fund (NYSE: SRV) Announces Distributions

Haoxi Health Technology Limited Announces Closing of $9,600,000 Initial Public Offering

GlobeNewswire

a year ago

Haoxi Health Technology Limited Announces Closing of $9,600,000 Initial Public Offering

Sypris Solutions (NASDAQ:SYPR) Is Looking To Continue Growing Its Returns On Capital

Simply Wall St.

a year ago

Sypris Solutions (NASDAQ:SYPR) Is Looking To Continue Growing Its Returns On Capital

Eagle Bancorp Montana Earns $2.2 Million, or 0.28 per Diluted Share, in the Fourth Quarter of 2023 and $10.1 Million, or $1.29 per Diluted Share, for the Year 2023

GlobeNewswire

a year ago

Eagle Bancorp Montana Earns $2.2 Million, or 0.28 per Diluted Share, in the Fourth Quarter of 2023 and $10.1 Million, or $1.29 per Diluted Share, for the Year 2023

Q3 Earnings Highs And Lows: RH (NYSE:RH) Vs The Rest Of The Home Furniture Retailer Stocks

StockStory

a year ago

Q3 Earnings Highs And Lows: RH (NYSE:RH) Vs The Rest Of The Home Furniture Retailer Stocks

Bright Scholar Announces Changes in Management

PR Newswire

a year ago

Bright Scholar Announces Changes in Management

LL Flooring Founder Drops Takeover Offer

Barrons.com

a year ago

LL Flooring Founder Drops Takeover Offer

Vicinity Motor Corp. Issues Shareholder Letter and Provides Corporate Update

ACCESSWIRE

a year ago

Vicinity Motor Corp. Issues Shareholder Letter and Provides Corporate Update

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?

Benzinga

a year ago

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?

Tigo Energy Announces Preliminary Financial Results and Reporting Date of February 13, 2024 for Fiscal Fourth Quarter and Full Year 2023

Business Wire

a year ago

Tigo Energy Announces Preliminary Financial Results and Reporting Date of February 13, 2024 for Fiscal Fourth Quarter and Full Year 2023

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

a year ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Oncocyte to Present at the Sequire Investor Summit in Puerto Rico

GlobeNewswire

a year ago

Oncocyte to Present at the Sequire Investor Summit in Puerto Rico

OFS Credit Company Provides December 2023 Net Asset Value Update

Business Wire

a year ago

OFS Credit Company Provides December 2023 Net Asset Value Update

Seth Klarman's Exit from Atara Biotherapeutics Inc

GuruFocus.com

a year ago

Seth Klarman's Exit from Atara Biotherapeutics Inc

Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited

PR Newswire

a year ago

Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited

YS Biopharma Announces Changes to its Board Committees

PR Newswire

a year ago

YS Biopharma Announces Changes to its Board Committees

Gannett to Present at the 26th Annual Needham Growth Conference

Business Wire

a year ago

Gannett to Present at the 26th Annual Needham Growth Conference

Apollomics Completes Patient Enrollment for Phase 3 Trial of Leukemia Treatment

Exec Edge

a year ago

Apollomics Completes Patient Enrollment for Phase 3 Trial of Leukemia Treatment

SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split

GlobeNewswire

a year ago

SAB Biotherapeutics Announces 1-for-10 Reverse Stock Split

Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock

Zacks

a year ago

Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

Business Wire

a year ago

The Central and Eastern Europe Fund, Inc., The European Equity Fund, Inc., and The New Germany Fund, Inc. Make Yearly Distribution Announcements

System1 to Participate in the 2024 ICR Conference

Business Wire

a year ago

System1 to Participate in the 2024 ICR Conference

Vista Gold Corp. Announces Receipt of the $3 Million First Installment Payment Under Wheaton Precious Metals Royalty

Business Wire

a year ago

Vista Gold Corp. Announces Receipt of the $3 Million First Installment Payment Under Wheaton Precious Metals Royalty

Vista Gold Corp. Announces $20 Million Royalty with Wheaton Precious Metals Corp. on Mt Todd

Business Wire

a year ago

Vista Gold Corp. Announces $20 Million Royalty with Wheaton Precious Metals Corp. on Mt Todd

The past five years for Ark Restaurants (NASDAQ:ARKR) investors has not been profitable

Simply Wall St.

a year ago

The past five years for Ark Restaurants (NASDAQ:ARKR) investors has not been profitable

Recent Drilling at TLC Significantly Expands Higher Grade, Near Surface Lithium Mineralization

GlobeNewswire

a year ago

Recent Drilling at TLC Significantly Expands Higher Grade, Near Surface Lithium Mineralization

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

GlobeNewswire

a year ago

Aligos Therapeutics Presents Positive Clinical Data at Hep-DART 2023 from Phase 1 Studies in HBV (ALG-000184) and NASH (ALG-055009)

Is CBL International Limited's (NASDAQ:BANL) 15% ROE Worse Than Average?

Simply Wall St.

a year ago

Is CBL International Limited's (NASDAQ:BANL) 15% ROE Worse Than Average?

Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays

GlobeNewswire

a year ago

Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays

GlobeNewswire

a year ago

Chijet Announces Financial Results for the Six Months Ended June 30, 2023

System1 to Report Third Quarter 2023 Financial Results

Business Wire

a year ago

System1 to Report Third Quarter 2023 Financial Results

Vroom Announces "At The Market" (ATM) Equity Offering Program

Business Wire

2 years ago

Vroom Announces "At The Market" (ATM) Equity Offering Program

Fathom Holdings Announces Proposed Primary and Secondary Offering of Common Stock

PR Newswire

2 years ago

Fathom Holdings Announces Proposed Primary and Secondary Offering of Common Stock

Entertainment Social Commerce Platform, PickleJar, Selects authID to Deliver Trusted Identity

GlobeNewswire

2 years ago

Entertainment Social Commerce Platform, PickleJar, Selects authID to Deliver Trusted Identity

Business Wire

2 years ago

First Seacoast Bancorp, Inc. Announces Balance Sheet Repositioning

GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference

GlobeNewswire

2 years ago

GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference

Here's What We Like About Ark Restaurants' (NASDAQ:ARKR) Upcoming Dividend

Simply Wall St.

2 years ago

Here's What We Like About Ark Restaurants' (NASDAQ:ARKR) Upcoming Dividend

Collaboratively Charting the Future of Auto Design: Italian Company TORINO Design Visits Chijet Motor

GlobeNewswire

2 years ago

Collaboratively Charting the Future of Auto Design: Italian Company TORINO Design Visits Chijet Motor

Here's What We Like About Magyar Bancorp's (NASDAQ:MGYR) Upcoming Dividend

Simply Wall St.

2 years ago

Here's What We Like About Magyar Bancorp's (NASDAQ:MGYR) Upcoming Dividend

The Kelly Services, Inc. (NASDAQ:KELY.A) Analysts Have Been Trimming Their Sales Forecasts

Simply Wall St.

2 years ago

The Kelly Services, Inc. (NASDAQ:KELY.A) Analysts Have Been Trimming Their Sales Forecasts

Battalion Oil Corporation Announces Third Quarter 2023 Financial and Operating Results

GlobeNewswire

2 years ago

Battalion Oil Corporation Announces Third Quarter 2023 Financial and Operating Results

Cambium (CMBM) Solution to Boost Connectivity in Rural Areas

Zacks

2 years ago

Cambium (CMBM) Solution to Boost Connectivity in Rural Areas

INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe

GlobeNewswire

2 years ago

INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer’s Disease in Europe

Wish Further Expands its Logistics as a Service (LaaS) Arm with the Launch of ‘WishPost Smart Parcel’

GlobeNewswire

2 years ago

Wish Further Expands its Logistics as a Service (LaaS) Arm with the Launch of ‘WishPost Smart Parcel’

Gabelli Funds and Columbia Business School to Host 5th Annual Healthcare Symposium

GlobeNewswire

2 years ago

Gabelli Funds and Columbia Business School to Host 5th Annual Healthcare Symposium

Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire

2 years ago

Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

MAGYAR BANCORP, INC. DECLARES SPECIAL CASH DIVIDEND

PR Newswire

2 years ago

MAGYAR BANCORP, INC. DECLARES SPECIAL CASH DIVIDEND

Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference

GlobeNewswire

2 years ago

Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference

OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon

GuruFocus.com

2 years ago

OncoCyte Corp (OCX) Reports Q3 2023 Financial Results with Key Product Launches on the Horizon

Oncocyte Reports Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Oncocyte Reports Third Quarter 2023 Financial Results

Radcom (RDCM) Q3 Earnings and Revenues Top Estimates

Zacks

2 years ago

Radcom (RDCM) Q3 Earnings and Revenues Top Estimates

Integra Files Technical Report for Updated Mineral Resource Estimate at the DeLamar Project

GlobeNewswire

2 years ago

Integra Files Technical Report for Updated Mineral Resource Estimate at the DeLamar Project

Associated Press Finance

2 years ago

FibroGen: Q3 Earnings Snapshot

Share on Social Networks: